POET Technologies' $400M Cash Haul Can't Shield It From Analyst Downgrades and Shareholder Lawsuits

Optical chipmaker POET Technologies struggles with stock slide, class-action suits, and PFIC tax issues despite $430M liquidity and Lumilens partnership.

A sharp disconnect has opened up between POET Technologies' financial firepower and its stock market fortunes. Just weeks after locking down a $400 million capital raise, the optical chip specialist finds itself under siege from a sell-side downgrade, multiple class-action lawsuits, and a 28% pullback from May's highs. The equity, which had surged more than 133% since the start of the year, closed at $14.78 on May 21 before 24/7 Wall St. slapped a "Sell" rating on it with a price target of $10.38 — implying a further 30% slide from that level. Analysts argue the rally has left the company's valuation untethered from its fundamental realities, even factoring in the strategic partnership with Lumilens.

The capital injection itself was substantial. On May 18, POET closed a direct placement that placed roughly 19 million new shares at $21 apiece, also issuing warrants exercisable over three years at $26.25 per share. The proceeds — which, together with existing cash, bring total liquidity to an estimated $430 million — are earmarked for a tenfold expansion of manufacturing capacity in Singapore and Malaysia, targeted acquisitions, and R&D. Management says the cushion covers roughly two and a half years of operations, buying time to convert a $50 million order from Lumilens into recurring revenue. That order, the first from the partner, comes with performance-based stock rights covering nearly 23 million POET shares.

But the recent operational numbers remain sobering. In the first quarter of 2026, revenue crept to roughly $503,000 — only slightly above expectations — while the net loss widened to $12.34 million from a profit in the same quarter a year earlier. Operating cash burn came in at about $8.8 million. The company's optical interposer platform, which integrates electronic and photonic components on a single chip to slash power and space in hyperscale data centers, is seen as a must-have for 800G and 1.6T AI networks. Yet turning that technological promise into profitable sales has so far proven elusive.

The legal headaches add another layer of uncertainty. Pomerantz LLP and several other firms have filed securities class actions alleging inadequate internal controls exposed confidential customer data through an NDA breach that, in April, supposedly cost POET orders from Celestial AI, a Marvell Technology affiliate. A separate claim targets the company's historical PFIC (Passive Foreign Investment Company) tax status, which has weighed on U.S. investors. Shareholders have until June 29 to apply as lead plaintiffs, meaning the litigation could drag on for months.

POET's management sees a structural fix for the PFIC problem: moving the corporate domicile and headquarters to the United States. Shareholders are scheduled to vote on the redomicile proposal at the annual meeting on June 26. Approval would resolve the tax classification and align the company's legal home with its primary market. Whether that move — combined with the hefty cash balance — can restore investor confidence remains an open question, especially with analysts pointing to a valuation that still appears stretched even after the recent pullback.